EDGAR Filing Documents for 0001493152-23-021848

Form 8-K - Current report:

SEC Accession No. 0001493152-23-021848

Filing Date

2023-06-20

Accepted

2023-06-20 16:15:29

Documents

Period of Report

2023-06-16

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	63165
2		ex10-1.htm	EX-10.1	77005
3		ex10-2.htm	EX-10.2	72424
	Complete submission text file	0001493152-23-021848.txt		421755

Data Files

Seq	Description	Document	Type	Size
4	XBRL SCHEMA FILE	prph-20230616.xsd	EX-101.SCH	3239
5	XBRL LABEL FILE	prph-20230616_lab.xml	EX-101.LAB	34240
6	XBRL PRESENTATION FILE	prph-20230616_pre.xml	EX-101.PRE	22367
8	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	3607

Mailing Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530

Business Address 711 STEWART AVE, SUITE 200 GARDEN CITY NEW YORK NY 11530 (215) 345-0919

ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)